Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 12/20 | 0.66 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 2/20 | 0.49 |
| ▸ | AGXT | P21549 | 1/20 | 0.49 |
| ▸ | PPARD | Q03181 | 3/20 | 0.48 |
| ▸ | PPARA | Q07869 | 2/20 | 0.48 |
| ▸ | PPARG | P37231 | 1/20 | 0.48 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.47 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.47 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.47 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.47 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.47 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13118336 | 0.91 | FFAR1 (0.76) | FFAR1MRGPRX4MAOBAGXTPPARD | |
| SCHEMBL12021108 | 0.90 | FFAR1 (0.64) | FFAR1MRGPRX4MAOBAGXTPPARD | |
| SCHEMBL3520170 | 0.89 | FFAR1 (0.62) | FFAR1MRGPRX4MAOBAGXTPPARD | |
| SCHEMBL14286071 | 0.85 | FFAR1 (0.62) | FFAR1MRGPRX4MAOBAGXTPPARD | |
| SCHEMBL13550367 | 0.83 | FFAR1 (0.74) | FFAR1MRGPRX4MAOBAGXTPPARD | |
| SCHEMBL13550323 | 0.83 | FFAR1 (0.79) | FFAR1MRGPRX4PPARDPPARAPPARG | |
| SCHEMBL12191648 | 0.83 | FFAR1 (0.86) | FFAR1 | |
| SCHEMBL3519034 | 0.82 | FFAR1 (0.60) | FFAR1MRGPRX4MAOBAGXTPPARD | |
| SCHEMBL13318210 | 0.82 | FFAR1 (0.68) | FFAR1MRGPRX4PPARDPPARAPPARG | |
| SCHEMBL13550339 | 0.82 | FFAR1 (0.74) | FFAR1MRGPRX4PPARDPPARAPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008030618-A1 | BENZO-FUSED COMPOUNDS FOR USE IN TREATING METABOLIC DISORDERS | AMGEN INC. (US) | 2008-03-13 | — | — | WO | disclosed |